Medications for Cardiovascular Risk Reduction
Drugs used to treat Cardiovascular Risk Reduction
The following list of medications are in some way related to, or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
simvastatin | 4.0 | 4 reviews | Rx | ||||
Generic name: simvastatin systemic Brand names: Zocor, FloLipid Drug class: statins For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
Jardiance | 1.0 | 4 reviews | Rx | ||||
Generic name: empagliflozin systemic Drug class: SGLT-2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Repatha | 4.5 | 47 reviews | Rx | ||||
Generic name: evolocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
Victoza | Rate | Add review | Rx | ||||
Generic name: liraglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Vascepa | 5.3 | 5 reviews | Rx | ||||
Generic name: icosapent systemic Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Invokana | Rate | Add review | Rx | ||||
Generic name: canagliflozin systemic Drug class: SGLT-2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Praluent | 5.9 | 14 reviews | Rx | ||||
Generic name: alirocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
Ozempic | 6.5 | 19 reviews | Rx | ||||
Generic name: semaglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Brilinta | Rate | Add review | Rx | ||||
Generic name: ticagrelor systemic Drug class: platelet aggregation inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Zocor | Rate | Add review | Rx | ||||
Generic name: simvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
ticagrelor | Rate | Add review | Rx | ||||
Generic name: ticagrelor systemic Brand name: Brilinta Drug class: platelet aggregation inhibitors For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
Trulicity | 5.0 | 4 reviews | Rx | ||||
Generic name: dulaglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
ramipril | 6.5 | 5 reviews | Rx | ||||
Generic name: ramipril systemic Brand name: Altace Drug class: Angiotensin Converting Enzyme Inhibitors For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
Micardis | Rate | Add review | Rx | ||||
Generic name: telmisartan systemic Drug class: angiotensin receptor blockers For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
telmisartan | 10 | 1 review | Rx | ||||
Generic name: telmisartan systemic Brand name: Micardis Drug class: angiotensin receptor blockers For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
empagliflozin | 1.0 | 4 reviews | Rx | ||||
Generic name: empagliflozin systemic Brand name: Jardiance Drug class: SGLT-2 inhibitors For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
liraglutide | Rate | Add review | Rx | ||||
Generic name: liraglutide systemic Brand name: Victoza Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
FloLipid | Rate | Add review | Rx | ||||
Generic name: simvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
alirocumab | 5.9 | 14 reviews | Rx | ||||
Generic name: alirocumab systemic Brand name: Praluent Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
Altace | Rate | Add review | Rx | ||||
Generic name: ramipril systemic Drug class: Angiotensin Converting Enzyme Inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Xarelto | 7.0 | 1 review | Rx | ||||
Generic name: rivaroxaban systemic Drug class: factor Xa inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
canagliflozin / metformin | Rate | Add review | Rx | ||||
Generic name: canagliflozin / metformin systemic Brand names: Invokamet, Invokamet XR Drug class: antidiabetic combinations For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts |
|||||||
evolocumab | 4.5 | 48 reviews | Rx | ||||
Generic name: evolocumab systemic Brand name: Repatha Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
rivaroxaban | 4.0 | 2 reviews | Rx | ||||
Generic name: rivaroxaban systemic Brand name: Xarelto Drug class: factor Xa inhibitors For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
semaglutide | 7.1 | 24 reviews | Rx | ||||
Generic name: semaglutide systemic Brand name: Ozempic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription Only. |
OTC | Over the Counter. |
Rx/OTC | Prescription or Over the Counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.